Kither Biotech
PrivateLast Round
Series B
Mar 16, 2022
Total Funding Raised
$26.58M
Momentum Score
50 /100
Company Overview
Kither Biotech is a biotechnology company developing signal transduction modulators for the treatment of rare respiratory diseases such as cystic fibrosis and idiopathic pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kither Biotech Comps
Public and private peers based on sector, stage, and business model.
Kither Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 16, 2022 | ||||
| Series A | Jul 5, 2019 |
Kither Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elysia Capital | Series A |
| Moschini Spa | Series A |
| Club degli Investitori | Series A, Series B |
| Claris Ventures | Series B |
| 2invest AG | Series B |
| CDP Venture Capital SGR | Series A, Series B |
| Invitalia Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2022
$20.26M raised in Series B funding.
- Jul 5, 2019
$6.32M round closed
Kither Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kither Biotech's valuation, stock price, and market status.
